Michael Lee Brooks - Jan 18, 2022 Form 4 Insider Report for Syneos Health, Inc. (SYNH)

Role: Chief Development Officer, Clinical Solutions
Signature: /s/ Sara Epstein, Attorney-in-Fact
Stock symbol: SYNH
Transactions as of: Jan 18, 2022
Transactions value $: -$207,477
Form type: 4
Date filed: 1/20/2022, 04:15 PM
Previous filing: Jan 3, 2022
Next filing: Feb 18, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SYNH	Class A Common Stock	Tax liability	-$95.9K	-1.11K	-3.38%	$86.09	31.9K	Jan 18, 2022	Direct
transaction	SYNH	Class A Common Stock	Award	$0	+7.42K	+23.26%	$0.00	39.3K	Jan 18, 2022	Direct	F1
transaction	SYNH	Class A Common Stock	Tax liability	-$112K	-1.3K	-14.83%	$86.09	7.44K	Jan 18, 2022	By spouse
transaction	SYNH	Class A Common Stock	Award	$0	+3.4K	+45.69%	$0.00	10.8K	Jan 18, 2022	By spouse	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an award of restricted stock units which vests in three approximately equal annual installments of 33 1/3% beginning on January 18, 2023, subject to continued employment.

Remarks:

Chief Development Officer, Clinical Solutions